Skip to Content
Home > About Us > Research and Grants Administration > Results
This study is being done to see if losing weight may help prevent breast cancer from coming back (recurring).
The purpose of this study is to compare any good and bad effects of using aspirin after someone has completed the usual chemotherapy, surgery and/or radiation therapy for breast cancer.
The purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum-based chemotherapy (cisplatin or carboplatin), after surgery for patients with triple-negative breast cancer.
The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin.
The purpose of this study is to compare the usual approach (i.e. no more treatment or additional post-operative chemotherapy), to any effects, good and/or bad, of the experimental drug MK-3475 (also called pembrolizumab) after surgery.
The purpose of this study is to find if adding the study drug, nivolumab (also known as OPVIDO®), will limit lung cancer from growing back in patients with early stage non-small cell lung cancer.
Researchers at The Ohio State University previously put together and tested From Cancer to HealthTM, a biobehavioral treatment designed specifically for cancer patients. Mental health professionals at Gilda’s Club Quad Cities have been trained to deliver the treatment to additional patients. This study will determine how effective the treatment is in reducing distress with new patients at Gilda’s Club Quad Cities.
The purpose of this study is to learn if adding an experimental drug, veliparib (also known as ABT-888), to a usual treatment is better than the usual treatment alone.
View Additional Section Content
For more information about our research program and IRB, please contact: